Shopping Cart 0
Cart Subtotal
USD 0

PledPharma AB (PLED) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

PledPharma AB (PledPharma) is a pharmaceutical company that discovers, manufactures, and develops drugs that protect the body against oxidative stress. The company discovers and develops Aladote and PledOx drugs. Its PledOX drug is used to prevent chemotherapy-induced side effects for colorectal cancer. PledPharma's products are also used in the therapeutic areas such as oncology and cardiology. The company also evaluates derivatives for conditions related to oxidative stress during treatment of life threatening diseases and also develops pharmaceuticals based on PLED substances. It also provides treatment for life-threatening illnesses based on the PLED technologies. PledPharma is headquartered in Stockholm, Sweden.

PledPharma AB (PLED)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

PledPharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

PledPharma AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

PledPharma AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

PledPharma AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

PledPharma AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

PledPharma AB, Pharmaceuticals & Healthcare, Deal Details 10

Licensing Agreements 10

Solasia Pharma Enters into Licensing Agreement with PledPharma 10

Equity Offering 11

PledPharma Raises USD46 Million in Rights offering of Shares 11

PledPharma Raises USD10 Million in Rights Offering of Shares 12

PledPharma AB-Key Competitors 13

PledPharma AB-Key Employees 14

PledPharma AB-Locations And Subsidiaries 15

Head Office 15

Recent Developments 16

Financial Announcements 16

Aug 22, 2018: PledPharma: half-year report january-june 2018 16

Apr 24, 2018: PledPharma: Interim Report January-March 2018 18

Feb 22, 2018: PledPharma: Year-end Report January-December 2017 20

Oct 20, 2017: Pledpharma: Interim report January-September 2017 22

Aug 30, 2017: PledPharma: Interim report January-June 2017 23

Apr 25, 2017: PledPharma: Interim report January-March 2017 25

Feb 24, 2017: PledPharma: Year end report January-December 2016 26

Corporate Communications 27

Apr 13, 2018: PledPharma announces Head of CMC and Supply Chain 27

Nov 07, 2017: PledPharma appoints Yilmaz Mahshid as new CFO 28

Sep 15, 2017: PledPharma's CFO to leave the company in December 2017 29

Aug 17, 2017: PledPharma appoints a Chief Medical Officer 30

Jun 29, 2017: PledPharma appoints vice president product strategy and development 31

Jun 16, 2017: Nicklas Westerholm takes office as CEO of PledPharma 32

Apr 06, 2017: PledPharma Appoints Nicklas Westerholm as New CEO 33

Product News 34

06/29/2017: PledPharma strengthens the management team with a Vice President Product Strategy and Development 34

Clinical Trials 35

Dec 01, 2017: First patient included in Phase I study aiming at supporting expansion of global Phase III program for PledOx to include Asian patients 35

Nov 17, 2017: PledPharma's Phase IIb study with PledOx (PLIANT) published in Acta Oncologica 36

Nov 16, 2017: PledPharma initiates Phase III studies with PledOx before year end 2017 37

Sep 14, 2017: The Aladote study in patients treated for paracetamol overdose is now open for recruitment for the next dosage group 38

Jun 08, 2017: First patient included in PledPharma's clinical trial with Aladote 39

Appendix 40

Methodology 40

About GlobalData 40

Contact Us 40

Disclaimer 40


List Of Figure

List of Figures

PledPharma AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

PledPharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

PledPharma AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

PledPharma AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

PledPharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

PledPharma AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

PledPharma AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

PledPharma AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

PledPharma AB, Pharmaceuticals & Healthcare, Key Facts, 2017 2

PledPharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

PledPharma AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

PledPharma AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

PledPharma AB, Deals By Therapy Area, 2012 to YTD 2018 8

PledPharma AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Solasia Pharma Enters into Licensing Agreement with PledPharma 10

PledPharma Raises USD46 Million in Rights offering of Shares 11

PledPharma Raises USD10 Million in Rights Offering of Shares 12

PledPharma AB, Key Competitors 13

PledPharma AB, Key Employees 14

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

PledPharma AB, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.